Edwards Lifesciencesvs.GE HealthCare
EW vs GEHC · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
Edwards Lifesciences is about 1.8× larger than GE HealthCare by market cap; GE HealthCare trades at the lower P/E (15.4 vs 48.0); year to date, Edwards Lifesciences leads (+8.2% vs −21.1%).
Side by side
| EW | GEHC | |
|---|---|---|
| Market cap | $52.6B | $29.4B |
| Price | $92.21 | $64.70 |
| Today | +1.0% | +0.0% |
| Return YTD | +8.2% | −21.1% |
| Return 1Y | +17.0% | −15.4% |
| P/E | 48.0 | 15.4 |
| P/S | 8.3 | 1.4 |
| P/B | 5.1 | 2.8 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Edwards LifesciencesEW
American specialist in heart valves and structural heart treatment — including transcatheter aortic valves (TAVR).
Full EW profile →GE HealthCareGEHC
Medical imaging (CT, MRI, ultrasound) and patient monitoring globally.
Full GEHC profile →More comparisons in Medtech & devices
See where EW and GEHC sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →